Global /South Korea /Healthcare /Medical Devices /214610
chevron_leftBack
RollingStone Co., Ltd. logo

RollingStone Co., Ltd.

214610
KRX: 214610 Delayed
2,290KRW -2.3%
1.50 USD
As of 13 June 2026, RollingStone Co., Ltd. has a market cap of $12.61M USD, ranking #40005 globally and #2522 in South Korea. It ranks #3568 in the Healthcare sector, and #756 in the Medical Devices industry.
Global Rank
40005
Country Rank
2522
Sector Rank
3568
Industry Rank
756
Key Stats
Market Cap
$12.61MUSD
19.18B KRW
Enterprise Value
$7.74MUSD
11.82B KRW
Revenue (TTM)
$586.32KUSD
891.68M KRW
EBITDA (TTM)
-$5.86MUSD
-8.94B KRW
Net Income (TTM)
-$13.86MUSD
-21.07B KRW
PS Ratio
21.5
PB Ratio
0.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Min Young Jeong open_in_new
Employees
48
Founded
2009
Website
rolling-stone.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.3% -9.7% -19% -46% -50% -59%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
214610
㈜)미코바이오메드
ISIN: KR7214610008
Shares Out.:
8.376M1 Shares Float: 2.726M2
TV:
SA:
YF:
GF:
BA:
MS:
2,290 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About RollingStone Co., Ltd.

RollingStone Co., Ltd. provides point-of-care-testing diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) system, a device that include membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; Veri-Q PCR 316 PB products; and LabChip, sample tube, and pre-filtering column products. It also provides biological chemistry products, including VERI-Q Multi, a cholesterol diagnostic product; VERI-Q Hb Mate and VERI-Q RED, a hemoglobin monitoring system; and VERI-Q PRO, a blood glucose monitoring system. In addition, the company offers immunodiagnostics products comprising VERI-Q COVID-19 Ag Rapid Test and VERI-Q COVID-19 IgGIgM Rapid Test for COVID testing; VERI-Q PinoView, a device for detecting markers of specific diseases through antigen-antibody reaction; and Opti96 ELISA plate/Kit. The company was formerly known as THE BioMed Co., Ltd. and changed its name to RollingStone Co., Ltd. in October 2025. RollingStone Co., Ltd. was founded in 2009 and is headquartered in Seongnam-si, South Korea.

Similar Companies

Industry: Medical Devices (South Korea)
Name
Market Cap diff.
PE
214150
$2.47B
3.75T KRW
19K%
28.7
458870
$1.23B
1.86T KRW
10K%
114.8
491000
$1.19B
1.81T KRW
9K%
-
290650
$1.14B
1.74T KRW
9K%
-
096530
$759.58M
1.16T KRW
6K%
23.9
214430
$532.37M
809.64B KRW
4K%
83.3
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
1M%
25.8
$160.73B
1M%
56.7
$159.07B
1M%
25.6
DHR
$126.55B
1M%
34.7
SYK
$120.69B
957K%
38.3
MDT
$101.9B
808K%
22.2
chevron_leftBack